Market Highlights:
Due to increasing occurrences of distinctive diseases across the globe, the demand for customized or personalized medicines manufactured with the help of genetic engineering is significantly up surged in past few years. The enhancements and technological innovations in genetic engineering will create numerous opportunities in the emerging economies that will ultimately help in improving the demand for genetic engineering. With the help of genetic engineering it is possible to directly manipulate an organism's genes using biotechnology. The market study is being classified by Type (Artificial Selection, Cloning, Gene Splicing and Others), by Application (Medical Industry, Recombinant Proteins, Recombinant Antibodies, Forensic Science and Others) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Key Players:
The prominent players in the Genetic Engineering are Thermo Fisher Scientific Inc. (United States), Merck KGaA (Germany), Horizon Discovery Group Plc. (United Kingdom), Transposagen Biopharmaceuticals Inc. (United States), New England Biolabs (United States), Genscript Biotech Corporation (United States), Lonza Group Ltd. (Switzerland) Inc. (United States), Origene Technologies, Inc. (United States), Integrated DNA Technologies, Inc. (United States) and CRISPR Therapeutics (Switzerland).

Major Market Development Highlights
On December 14, 2018, Merck, which is also known as MSD outside North America is a privately held Antelliq Group has announced that the companies have signed a definitive agreement under which Merck will acquire Antelliq with a cash payment of approximately 2.1 billion euros to acquire all outstanding shares of Antelliq and will assume Antelliq’s debt of 1.15 billion euros, which it intends to repay shortly after the closing of the acquisition.


Key Questions Answered in the Report
What will the Genetic Engineering Market size and the growth rate be in Future?
What are the key factors driving the Genetic Engineering Market?
What are the key market trends and macro-economic impacting the growth of the Genetic Engineering Market?
What are the challenges to market growth?
Who are the key vendors in the Genetic Engineering Market?
What are the market opportunities and threats faced by the vendors in the Genetic Engineering Market?
Trending factors influencing the market shares of the Players.
What are the key outcomes of the five forces analysis of the Genetic Engineering Market?

Refer complete Table of Content of Genetic Engineering Market Study

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Genetic Engineering market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Genetic Engineering market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Government Research Laboratories, Government and Independent Regulatory Authorities, Market Research and Consulting Service Providers, Genetic Engineering Product Manufacturers, Genetic Engineering Product Suppliers, Contract Research Organizations (CROs), Research and Development (R&D) Companies, Academic Institutes and Universities and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.